Berry Consultants
17
8
9
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
5.9%
1 terminated/withdrawn out of 17 trials
75.0%
-11.5% vs industry average
41%
7 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Staphylococcus Aureus Network Adaptive Platform Trial
Role: collaborator
StrokeNet Thrombectomy Endovascular Platform
Role: collaborator
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Role: collaborator
Better Evidence and Translation for Calciphylaxis
Role: collaborator
Esophageal Protection Study: A Multicenter Study
Role: collaborator
RECOMMEND Platform Trial
Role: collaborator
ACT-GLOBAL Adaptive Platform Trial for Stroke
Role: collaborator
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Role: collaborator
REMAP Trial for Optimizing Surgical Outcomes at UPMC
Role: collaborator
High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients With AcuTE Respiratory Failure
Role: collaborator
Intranasal Oxytocin for Frontotemporal Dementia
Role: collaborator
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Role: collaborator
All 17 trials loaded